Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04748601 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT04748601 · ClinicalTrials.gov record · last posted 2025-01-27

Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old

StatusRecruiting
PhasePhase 4
Started2021-02-19
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
A Phase 4 study to evaluate Qudexy XR for the prevention of migraine in children 6 to 11 years of age.

Amendment record 8 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 8 times since 2021-02-05; most recent amendment 2025-01-22. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2021-03-31
Status change Not Yet Recruiting→Recruitingv1
Trial Details
NCT Number NCT04748601
Lead Sponsor Upsher-Smith Laboratories
Conditions Migraine Disorders
Enrollment 132 participants
Start Date 2021-02-19
Primary Completion 2026-09 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2025-01-27